Mesa Laboratories Appoints Mark Capone to its Board of Directors
January 8, 2024
LAKEWOOD, Colo. -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us”, or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the “Board”), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board [...]
Teledyne LABS is new distributor of Ecodyst rotary evaporation systems for the laboratory
January 8, 2024
Teledyne LABS is now a major distributor of Ecodyst evaporation systems used in laboratories worldwide. Ecodyst uses proprietary technology for the efficient and gentle removal of solvent from samples in numerous advanced scientific processes. Principle users of Teledyne LABS chromatography instruments and Ecodyst benchtop rotary evaporator (rotavap) and large-scale evaporation systems include the pharmaceutical and [...]
January 7, 2024
The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of RNA and protein biomarkers MARLBOROUGH, Mass.-- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that it has entered into a license and distribution agreement with Thermo Fisher Scientific, Inc. The agreement enables [...]
Depixus Launches Technology Access Program With First MAGNA One™ Instrument Placement
January 5, 2024
PARIS, France – Interactomics pioneer Depixus has launched its game-changing MAGNA technology access program with the deployment of the first ‘MAGNA One’ beta prototype instrument in the laboratory of Professor Jean-François Allemand, Department of Physics at the École Normale Supérieure (ENS), Paris. Based on magnetic force spectroscopy, MAGNA is the first technology to deliver direct, simultaneous, [...]
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
January 5, 2024
SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen). This collaboration will be the first relating to the development of Illumina's novel molecular residual disease (MRD) assay, a whole-genome sequencing (WGS) multi-cancer research solution that [...]
January 5, 2024
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim Kelderman, who will become Bio-Techne's Chief Executive Officer effective February 1, 2024. Dr. McManus has over two decades of experience as a senior life sciences leader, most recently serving as [...]
STRATEGIC ALLIANCE OF TWO QUALITY LEADERS
January 5, 2024
In 2023, Hettich Group experienced its most lucrative year yet in its 120-year history. For the first time, the Tuttlingen-based global leader, specializing in centrifuges and incubators for clinical-medical applications across three European locations, significantly surpassed the 100 million euro threshold in revenue. In addition to this outstanding organic growth, the strategic growth trajectory was [...]
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 5, 2024
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Adam Laponis as chief financial officer. Mr. Laponis brings experience across small cap and Fortune 50 companies along with a track record of collaborating across teams to drive [...]
January 5, 2024
Establishes Leading Platform of Complementary Multi-omic Technologies with Enhanced Scale and Commercial Reach; Strengthened Balance Sheet to Self-Fund Future Growth Initiatives SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that it has completed its merger with SomaLogic, [...]
January 4, 2024
Dr Peter Selders takes over as CEO, Matthias Altendorf new president of the Supervisory Board Endress+Hauser has completed the announced change at the top of the Group: Dr Peter Selders has taken over as CEO of the Swiss specialist for measurement technology and automation solutions. The 54-year-old holds a doctorate in physics, has been with [...]

